Evaluation of immunohistochemical staining using whole-slide imaging for HER2 scoring of breast cancer in comparison with real glass slides

Pathology International

Volumn 62, Issue 9, 2012, Pages 592-599

  Kondo, Yuzuru ^a   Iijima, Tatsuo ^b   Noguchi, Masayuki ^b  

^a UNIVERSITY OF TSUKUBA HOSPITAL   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Breast cancer; HER2; Immunohistochemistry; Whole slide imaging

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; AGED; ARTICLE; BREAST CANCER; CLINICAL EVALUATION; COMPARATIVE STUDY; COMPUTER; CONTROLLED STUDY; DIAGNOSTIC KIT; DIGITAL IMAGING; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROSCOPY; PATHOLOGIST; PRIORITY JOURNAL; TISSUE SECTION; VALIDITY; WHOLE SLIDE IMAGING;

ADULT; AGED; APOCRINE GLANDS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; DIAGNOSTIC IMAGING; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MICROSCOPY; MIDDLE AGED; OBSERVER VARIATION; PATHOLOGY, SURGICAL; QUESTIONNAIRES; RECEPTOR, ERBB-2; REPRODUCIBILITY OF RESULTS;

EID: 84865553049     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2012.02847.x     Document Type: Article

References (17)

1. Wilbur DC, Madi K, Corvin RB etal. Whole-slide imaging digital pathology as a platform for teleconsultation: A pilot study using paired subspecialist correlations. Arch Pathol Lab Med 2009; 133: 1949-53.
2. Horbinsli C, Fine JL, Medina-Flores R, Yagi Y, Wiley CA. Telepathology for intraoperative neuropathologic consultations at an academic medical center: A 5-year report. J Neuropathol Exp Neurol 2007; 66: 750-9.
3. Kumar RK, Freeman B, Velan GM, De Permentier PJ. Integration histology and histopathology teaching in practical classes using virtual slides. Anat Rec B New Anat 2006; 289: 128-33.
4. Weinstein RS, Graham AR, Richter LC etal. Overview of telepathology, virtual microscopy, and whole slide imaging: Prospects for the future. Hum Pathol 2009; 40: 1057-69.
5. Marchevsky AM, Khurana R, Thomas P, Scharre K, Farias P, Bose S. The use of virtual microscopy for proficiency testing in gynecologic cytopathology: A feasibility study using ScanScope. Arch Pathol Lab Med 2006; 130: 349-55.
6. López AM, Graham AR, Barker GP etal. Virtual slide telepathology enables an innovative telehealth rapid breast care clinic. Semin Diagn Pathol 2009; 26: 177-86.
7. Ho J, Parwani AV, Jukic DM, Yagi Y, Anthony L, Gilbertson JR. Use of whole slide imaging in surgical pathology quality assurance: Design and pilot validation studies. Hum Pathol 2006; 37: 322-31.
8. Johnston DJ, Costello SP, Dervan PA, O'Shea DG. Development and preliminary evaluation of the VPS ReplaySuite: A virtual double-headed microscope for pathology. BMC Med Inform Decis Mak 2005; 5: 10.
9. Evans AJ, Chetty R, Clarke BA etal. Primary frozen section diagnosis by robotic microscopy and virtual slide telepathology: The University Health Network experience. Semin Diagn Pathol 2009; 26: 165-76.
10. Costello SS, Johnston DJ, Dervan PA, O'Shea DG. Development and evaluation of the virtual pathology slide: A new tool in telepathology. J Med Internet Res 2003; 5: e11.
11. Gilbertson JR, Ho J, Anthony L, Jukic DM, Yagi Y, Parwani AV. Primary histologic diagnosis using automated whole slide imaging: A validation study. BMC Clin Pathol 2006; 6: 4.
12. Vogel CL, Cobleigh MA, Tripathy D etal. Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J Clin Oncol 2002; 20: 719-26.
13. Shak S. Overview of the trastuzumab (Herceptin) anti-HER2 monoclonal antibody clinical program in HER2-overexpressing metastatic breast cancer. Herceptin Multinational Investigator Study Group. Semin Oncol 1999; 26: 71-7.
14. Slamon DJ, Leyland-Jones B, Shak S etal. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001; 344: 783-92.
15. Pathological Committee for Optimal Use of Trastuzumab. HER2 ATLAS. Tokyo: Chugai Pharmaceutical Co., Ltd, 2004.
16. Umemura S, Sakamoto G, Sasano H etal. Evaluation of HER2 status: For the treatment of metastatic breast cancers by humanized anti-HER2 Monoclonal antibody (trastuzumab) (Pathological committee for optimal use of trastuzumab). Breast Cancer 2001; 8: 316-20.
17. Sim J, Wright CC. The kappa statistic in reliability studies: Use, interpretation, and sample size requirements. Phys Ther 2005; 85: 257-68.